We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

75 hedge funds and large institutions have $137M invested in Filana Therapeutics in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,002% more call options, than puts

Call options by funds: $988K | Put options by funds: $47K

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

50% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 16

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

21% more funds holding

Funds holding: 62 → 75 (+13)

18% more capital invested

Capital invested by funds: $115M → $137M (+$21.2M)

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
2.17%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
22
Increased
24
Reduced
16
Closed
8
Calls
$988K
Puts
$47K
Net Calls
+$941K
Net Calls Change
+$609K

Top Buyers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
+$3.71M
2
MSP
Madison Street Partners
Colorado
+$2.57M
3
GIM
Granahan Investment Management
Massachusetts
+$1.14M
4
Morgan Stanley
Morgan Stanley
New York
+$961K
5
BIM
Bogle Investment Management
Massachusetts
+$866K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$2.57M
2
BC
Broadfin Capital
New York
-$2.27M
3
SC
Sophrosyne Capital
New York
-$1.64M
4
6CM
683 Capital Management
New York
-$1.35M
5
Renaissance Technologies
Renaissance Technologies
New York
-$777K
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
51
AQR Capital Management
Connecticut
$226K +$207K +5,871 New
PA
52
Perceptive Advisors
New York
$194K – – –
LP
53
LMR Partners
United Kingdom
$191K +$175K +4,967 New
ARTA
54
A.R.T. Advisors
New York
$173K +$159K +4,500 New
State Street
55
State Street
Massachusetts
$153K – – –
EEG
56
E.E. Geduld
$138K +$126K +3,571 New
BG
57
BlackRock Group
United Kingdom
$115K +$105K +2,981 New
Charles Schwab
58
Charles Schwab
California
$103K – – –
Wells Fargo
59
Wells Fargo
California
$97K +$89K +2,521 New
PP
60
PDT Partners
New York
$86K +$79.2K +2,243 New
Two Sigma Advisers
61
Two Sigma Advisers
New York
$82K +$74.3K +2,106 New
STIA
62
Stone Toro Investment Advisers
New Jersey
$77K +$70.6K +2,000 New
CAS
63
CTC Alternative Strategies
Illinois
$62.7K +$57.5K +1,629 New
BA
64
BlackRock Advisors
Delaware
$49K -$371K -10,508 -89%
Canada Pension Plan Investment Board
65
Canada Pension Plan Investment Board
Ontario, Canada
$15K +$14.1K +400 New
Citigroup
66
Citigroup
New York
$13K +$11K +311 +1,728%
NES
67
New England Securities
New York
$7K – – –
TRCT
68
Tower Research Capital (TRC)
New York
$4K -$35 -1 -1%
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$3.35K – – –
AllianceBernstein
70
AllianceBernstein
Tennessee
$3K – – –
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$2K -$71 -2 -4%
TCOV
72
Trust Company of Vermont
Vermont
$2K – – –
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10 – – –
MCM
74
Munder Capital Management
Michigan
– -$620K -18,236 Closed
ZIM
75
Zacks Investment Management
Illinois
– -$337K -9,891 Closed
1 2
3
4

FLNA Hedge Fund Activity: Q1 2014 in Review

75 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2014, worth a combined $137M — up 18% from $115M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FLNA positions and 8 closed out — a net gain of 14 holders — while 24 added to existing stakes and 16 trimmed.

The largest buyer was First Eagle Investment Management, adding an estimated $3.71M. The largest seller was Great Point Partners, cutting an estimated $2.57M.

  • 75 institutional investors held Filana Therapeutics (FLNA) as of Q1 2014, up from 62 in Q4 2013.
  • Funds reported $137M of Filana Therapeutics stock for Q1 2014, up 18% quarter-over-quarter.
  • 22 funds opened new Filana Therapeutics positions in Q1 2014 and 8 closed out, a net change of +14 holders.
  • The largest Filana Therapeutics buyer in Q1 2014 was First Eagle Investment Management, an estimated $3.71M added.
  • The largest Filana Therapeutics seller in Q1 2014 was Great Point Partners, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2014.